COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
By PCCA
Over 300 PCCA members attended International Seminar live and virtually in October 2021. They shared best practices with each other, made new contacts and reconnected with colleagues. Meanwhile, experts from Clinical Services and other PCCA departments attended sessions and absorbed as much as they could, when they weren’t presenting on various topics or connecting with members one on one. Here are just some of the gems that they found while attending presentations and roundtables at the pharmacy compounding industry’s biggest event.
Presented by Clint Pulver
Presented by Jeff Carson, RPh; Peter Koshland, PharmD; Jasper Lovoi III, PharmD; and Gopesh Patel, RPh
Presented by Loyd Allen, PhD, RPh
Intranasal theophylline treatment improved taste and smell in eight of 10 patients after four weeks in a 2012 study by Henkin et al.
Presented by Dian Ginsberg, MD, FACOG
Presented by Sebastian Denison, RPh, FAARM (cand.)
Presented by Ross Caputo, PhD
With a growth mindset, you can identify opportunities in the process workflow, plan how the process can be improved, execute and implement changes, and review how the changes are working for the team.
Presented by Nat Jones, RPh, FAPC, and John Preckshot, RPh, CCN, FAARM
Patients with severe fibromyalgia experienced short-term improvements from topical capsaicin 0.075% treatment three times daily for six weeks, according to a 2013 study by Casanueva et al.
Presented by Pamela Smith, MD, MPH, MS
Many hormones have direct effects on the microbiome, including estrogen, progesterone, testosterone, DHEA, cortisol, insulin, melatonin, growth hormone, thyroid hormones and parathyroid hormone. The microbiome also affects these hormones. The great news is the innovative field of microbial endocrinology affords us new opportunities to help patients achieve optimal health.
Moderated by Erin Michael, MBA, MS, CPhT, PCCA Director of Member Engagement, and Kim Speairs, APR, MBA, PCCA Director of Communications
Presented by Richard Harris, PharmD, MD, MBA
Chronic inflammation leads to dysregulation of body systems and disease. Associated symptoms include:
Presented by Sara Hover, RPh, FAARM
According to Passos et al. (2015) , post-traumatic stress disorder (PTSD) is associated with increased levels of the inflammatory markers interleukin 6, interleukin 1β, tumor necrosis factor α and interferon γ.
The brain’s first goal is survival — everyone is listening to the radio station WIIFM (what’s in it for me) — so give your patients and prescribers the bottom line upfront.
Visit PCCAInternationalSeminar.com for information on next year’s event. These statements are provided for educational purposes only. They have not been evaluated by the Food and Drug Administration, and are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment.